Quick Answer
Galmed Pharmaceuticals Ltd. reported Diluted EPS of $2.39 per share for fiscal year 2025.
Galmed Pharmaceuticals Ltd. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $2.39 | -70.4% |
| 2024 | $8.08 | -73.1% |
| 2023 | $30.00 | -76.5% |
| 2022 | $127.80 | +545.5% |
| 2021 | $19.80 | — |
- Galmed Pharmaceuticals Ltd. showed a decrease of -70.4% in Diluted EPS compared to the prior fiscal year.
- Over the 2021–2025 period, Galmed Pharmaceuticals Ltd.’s diluted eps has declined by 87.9% (from $19.80 per share to $2.39 per share).
- The most recent figure is from Galmed Pharmaceuticals Ltd.’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: